Archway Apothecary Acquires Exclusive Rights to Distribute Lunglaid(TM) for Asthma Management

Archway Apothecary Acquires Exclusive Rights to Distribute Lunglaid(TM), a Medical Food that PromotesLeukotriene Homeostasis in Patients with Asthma

COVINGTON, LA / ACCESSWIRE / June 30, 2015 / Archway Apothecary is now the exclusive distributor of Lunglaid(TM), a safe medical food emulsion with natural, highly refined fish oils for dietary management to promote leukotriene homeostasis in children ages 2-17 with persistent asthma.

Lunglaid(TM) initially began with research at Wake Forest University School of Medicine and later continued with successful clinical studies on asthma patients, demonstrating a reduction in asthma symptoms, reduced reliance on rescue medication, and showing improved asthma-related quality of life. Lunglaid(TM), as a medical food, addresses a nutritional deficiency of low GLA and EPA, key fatty acids proven to reduce leukotriene levels.

As a medical food emulsion, Lunglaid(TM) addresses the growing demand for safe, natural-based alternatives to traditional asthma drug therapy with montelukast and its extensive list of adverse reactions, including neuropsychiatric events such as agitation, aggressive behavior or hostility, anxiousness, depression, and suicidal thinking. Adverse effects noted with Lunglaid(TM) during clinical studies at the intended dose were unremarkable, reversible and not significantly different from placebo. For more information on Lunglaid’s clinical studies, safety profile and dosing requirements visit www.lunglaid.net.

ABOUT ARCHWAY APOTHECARY

Archway Apothecary is a state-of-the art, sterile compounding and retail pharmacy based in Covington, LA with distribution throughout the United States. It is also a member of the PCCA and IACP associations. For more information on Archway Apothecary visit www.archwayapothecary.com.

Media Contact:

Dan Feltham
(985) 801-0800
info@archwayapothecary.com

SOURCE: Archway Apothecary

ReleaseID: 430253